Advancing Treatment for NRG1 Fusion+ Lung and Pancreatic Cancers - Episode 7

Choosing RNA Over DNA Testing for NRG1 Fusions in Pancreatic Cancer

June 14, 2024

E. Gabriela Chiorean, MD, of Fred Hutch Cancer Center, discusses the benefits and challenges of DNA and RNA testing for NRG1 fusions in patients with pancreatic cancer.

EP. 1: Prevalence of NRG1 Fusions in Lung Cancer

EP. 2: Differences Between DNA and RNA Testing for NRG1

EP. 3: Standard Treatments for NRG1 Fusion+ NSCLC

EP. 4: Ongoing Research Efforts Targeting NRG1 in Lung Cancer

EP. 5: Efficacy With NRG1-Directed Agents in NSCLC

EP. 6: Prognosis, Rarity of NRG1+ Pancreatic Cancer

Now Viewing

EP. 7: Choosing RNA Over DNA Testing for NRG1 Fusions in Pancreatic Cancer

EP. 8: Standard Treatment Regimens for NRG1+ Pancreatic Cancer

EP. 9: Poised Potential With Zenocutuzumab in NRG1+ Pancreatic Cancer